New England Journal of Medicine Publishes New Data for Genentech's Gazyva Which Shows Superiority Over Standard Therapy in People With Active Lupus Nephritis
New England Medicine magazine publishes new Genentech Gazyva data that shows priority on standard therapy of people with active Lupos Nephritis
Report